6533b859fe1ef96bd12b78c9
RESEARCH PRODUCT
Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections
Ali A. RizviAles LinhartMichal VrablikEvangelos LiberopoulosRizzo Manfredisubject
Dipeptidyl-Peptidase IV InhibitorsDiabetes Mellitus Type 2HumansHypoglycemic Agentsincretins diabetesPharmacology (medical)General MedicineIncretinsyear | journal | country | edition | language |
---|---|---|---|---|
2022-02-22 |